3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Fatigue
1
Cognitive Dysfunction
1
Interventions
Exercise
5
Cognitive Behavioral Therapy
4
Surveys and Questionnaires
3
Educational Status
3
Therapeutics
2
Palliative Care
2
Methylphenidate
2
Dexamethasone
2
Counseling
2
Control Groups
2
Calcium Dobesilate
2
Acupressure
2
Acceptance and Commitment Therapy
2
pegfilgrastim
1
enzalutamide
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
darolutamide
1
auricularum
1
apalutamide
1
Therapeutic Touch
1
Testosterone
1
Surgical Procedures, Operative
1
Sugars
1
Standard of Care
1
Sildenafil Citrate
1
Self-Help Groups
1
Relaxation Therapy
1
Radiotherapy
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fatigue
×
Modafinil
×
1 year
×
Clear all
NCT05333250
2026-01-13
MODIFY
Ottawa Hospital Research Institute
Phase 1/2
Recruiting
40 enrolled